Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Half a million seniors are already on board. Just two months after launching, Medicare's new Bridge program has enrolled 600,000 older Americans for GLP-1 weight-loss medications at just $50 a month. The rapid uptake signals massive pent-up demand for affordable obesity treatment among seniors.
The Medicare Bridge program, which launched in July, is off to a roaring start. CMS Administrator Dr. Mehmet Oz announced that 600,000 seniors have already signed up to receive GLP-1 weight-loss medications through the new federal initiative — all within its first two months of operation.
The program was designed to dramatically expand access to highly sought-after obesity treatments for older Americans, who were previously largely shut out of Medicare coverage for these drugs. Under the Bridge program, eligible seniors can access GLP-1 medications for as little as $50 a month — a steep discount compared to the drugs' typical list prices.
By the Numbers:
Why it matters: The rapid enrollment figures underscore just how significant the unmet need for affordable obesity care is among the senior population. If this pace continues, the program could reshape how GLP-1 drugs are accessed and prescribed at scale across the U.S.
